Tanzanian Government: Hepatitis B Prevalence Drops to 3.5%

• Hepatitis B prevalence in Tanzania has fallen to 3.5% from 4% in 2022.
• Hepatitis C prevalence has dropped sharply to 0.1% from 1%.
• The Tanzanian government aims to eliminate viral hepatitis by 2030.
• Public awareness campaigns have been intensified through media, social media, and community outreach programs.

The government remains firmly committed to eliminating viral hepatitis as a public health threat by 2030.

Tanzania has made significant strides in reducing the prevalence of hepatitis B and C, with recent studies indicating that hepatitis B prevalence has fallen to 3.5% from 4% in 2022, while hepatitis C prevalence dropped sharply to 0.1% from 1%. This progress is a testament to the government's efforts to prevent, diagnose, and treat the disease. The Acting Chief Medical Officer, Dr Eliudi Eliakimu, released the figures as part of World Hepatitis Day celebrations, which aimed to break down barriers to lifesaving hepatitis prevention, testing, and treatment services.

The Tanzanian government's commitment to eliminating viral hepatitis by 2030 is a significant development for businesses operating in the country. Lawyers advising clients on business operations in Tanzania should be aware of this effort, which may impact compliance with health and safety regulations. The government has expanded hepatitis screening and treatment services to various hospitals, strengthened early diagnosis and referral systems at health centers and dispensaries, and intensified public awareness campaigns through media, social media, and community outreach programs.

The reduction in hepatitis B and C prevalence is a significant achievement for Tanzania's public health. However, the disease remains a major challenge, with hepatitis B being the most common form of the disease. To build on this progress, it is essential to continue expanding access to screening and treatment services, particularly for high-risk groups such as pregnant women, healthcare workers, and people who inject drugs. Moreover, public awareness campaigns should be sustained to encourage early testing, vaccination, and prompt medical care.

Lawyers advising clients on business operations in Tanzania should be aware of the government's efforts to eliminate viral hepatitis by 2030, which may impact compliance with health and safety regulations.

Source: Original reporting via [Source]